Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengxian Quyu Huazhuo granules
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Henan University of Chinese Medicine
- Administration
- Oral
01
Overview
Shengxian Quyu Huazhuo granules is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Henan University of Traditional Chinese Medicine for the treatment of coronary heart disease (CHD). The name reflects its therapeutic principles: "Shengxian" refers to regulating the lifting and sinking of qi, while "Quyu Huazhuo" refers to removing blood stasis and resolving phlegm turbidity. It is intended for patients exhibiting TCM syndromes of qi deficiency and phlegm stasis. The drug is currently being evaluated in clinical trials as an add-on to standard Western medical therapy to assess its impact on cardiopulmonary exercise capacity, angina symptoms, and the incidence of major adverse cardiovascular events (MACE).
- Other names
- Shengxian Quyu Huazhuo
02
Targets
IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)TP53 (Cellular Tumor Antigen p53 R175H)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Shengxian Quyu Huazhuo granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shengxian Quyu Huazhuo granules.